SAN DIEGO & SAN FRANCISCO–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting. iRhythm is a digital healthcare company that provides ambulatory electrocardiogram monitoring […]
Financial
Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Carol Murdock as Chief Commercial Officer. She will lead Business Development, Account Management, Marketing and Corporate Communications, reporting to Mr. Terren Peizer, Chairman and CEO. Ms. Murdock joins the […]
Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SUNNYVALE, Calif., April 08, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of its initial public offering of 6,000,000 shares of common stock, and the exercise in full of the […]
Frank J. Quintero Joins BioSig Technologies Advisory Board
Santa Monica, CA, April 09, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Frank J. Quintero, a Los Angeles-based investor, joined the Advisory Board of the Company. Mr. […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced preliminary unaudited revenue results for the quarter ended March 31, 2019.
Preliminary First Quarter 2019 Results The Company expects worldwide sales from continuing operations for the first quarter 2019 to be approximately $251 million, flat on a reported basis and an increase of 4.0 percent on a constant-currency basis compared to the first quarter of 2018. Neuromodulation sales are anticipated to […]
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
FRANKLIN LAKES, N.J., April 4, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2019 earnings conference call on Thursday, May 9, 2019, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter’s earnings earlier that morning. The […]
AtriCure to Announce First Quarter 2019 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2019 financial results on Thursday, April 25, 2019. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday, […]
InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock
Email Print Friendly Share April 04, 2019 06:00 ET | Source: InspireMD, Inc. TEL AVIV, Israel, April 04, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced the pricing of its previously […]
Milestone Pharmaceuticals Appoints Michael Tomsicek to Board of Directors
MONTREAL and CHARLOTTE, N.C., April 4, 2019 /PRNewswire/ — Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular indications, today announced the appointment of Michael Tomsicek to its Board of Directors. Mr. Tomsicek is currently the Chief Financial Officer of CRISPR Therapeutics, a biopharmaceutical company focused on developing gene-based medicines. In addition […]
Silk Road Medical Announces Pricing of Initial Public Offering
SUNNYVALE, Calif., April 03, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq:SILK) (“Silk Road Medical”) today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $20.00 per share. All of the shares of common stock are being offered by Silk […]



